Stocksigma LogoStocksigma Logo

Supriya Lifescience Reports Q2 FY27 Results and Appoints COO

For the quarter ended 30th Sep'26, Supriya Lifescience reported standalone revenue from operations of ₹2,062.97 mn, up 3.2% YoY and 8.7% QoQ

Supriya Lifescience Reports Q2 FY27 Results and Appoints COO

Supriya Lifescience Ltd · Outcome · 06 Nov 2026, 6:25 pm

Supriya Lifescience Reports Q2 FY27 Results and Appoints COO For the quarter ended 30th Sep'26, Supriya Lifescience reported standalone revenue from operations of ₹2,062.97 mn, up 3.2% YoY and 8.7% QoQ. Net profit declined 42.0% YoY to ₹292.50 mn from ₹504.27 mn in Q2 FY26, though it grew 21.7% QoQ. Total expenses increased to ₹1,708.11 mn from ₹1,342.40 mn YoY. H1 FY27 revenue reached ₹3,960.44 mn with net profit at ₹532.93 mn. Additionally, the board approved the appointment of Mr. Mangesh Vaze as Chief Operating Officer, effective 6th Nov'26.

Original exchange filing (PDF)

More announcements from Supriya Lifescience Ltd

All Supriya Lifescience Ltd announcements